The Feasibility of PetCO2 Prediction Hypotension Under Spinal Anesthesia for Cesarean Section
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02032355|
Recruitment Status : Unknown
Verified January 2014 by Geng guiqi, Fudan University.
Recruitment status was: Recruiting
First Posted : January 10, 2014
Last Update Posted : January 10, 2014
Maternal hypotension is a common side effect after spinal anesthesia for cesarean delivery.Decreased vascular resistance and cardiac output, due to sympathetic blockade1and blood pooling in blocked areas of the body respectively, are main causes of spinal anaesthesia-induced hypotension during Caesarean delivery.
Cardiac output, which has shown to be a better predictor of organ and placental perfusion than arterial blood pressure.Few studies have measured CO after spinal anesthesia in the maternal population.This is largely because of the lack of availability of accurate and reproducible noninvasive measurement techniques. Up to now, preventing hypotension has continued to focus on arterial blood pressure variables, fluid, and ephedrine requirements as markers of cardiovascular status, because these are more easily measured.
Investgators hypothesized that CO and PetCO2, in parturients with the degree of hypotension during spinal anaesthesia, would also have a positive and significant association.
|Condition or disease||Intervention/treatment|
|Hypotension Carbon Dioxide||Procedure: spinal anesthesia|
|Study Type :||Observational|
|Estimated Enrollment :||6 participants|
|Official Title:||The Feasibility of PetCO2 Prediction Hypotension Under Spinal Anesthesia for Cesarean Section|
|Study Start Date :||January 2014|
|Estimated Primary Completion Date :||February 2014|
|Estimated Study Completion Date :||February 2014|
Procedure: spinal anesthesia
- value of PetCO2 and changes in artery pressure [ Time Frame: up to 4 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02032355
|Obstetrics & Gynecology Hospital, Fudan University||Recruiting|
|Shanghai, Shanghai, China, 200090|
|Contact: congjian xu, PhD 86 2163455050 firstname.lastname@example.org|